List of bibliographic references
Number of relevant bibliographic references: 61.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000061 (1999) |
M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France] | The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease. |
| 000062 (1999) |
O. Rascol [France] | L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach. |
| 000064 (1999) |
J L Montastruc [France] ; O. Rascol ; J M Senard | Treatment of Parkinson's disease should begin with a dopamine agonist. |
| 000079 (1999) |
E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E Gross | Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. |
| 000080 (1999) |
Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. Tolosa | Levodopa in the treatment of Parkinson's disease: a consensus meeting. |
| 000163 (2001) |
O. Rascol [France] ; J G Nutt ; O. Blin ; C G Goetz ; J M Trugman ; C. Soubrouillard ; J H Carter ; L J Currie ; N. Fabre ; C. Thalamas ; W W Giardina ; S. Wright | Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. |
| 000174 (2001) |
F. Durif [France] ; I. Devaux ; J J Pere ; J C Delumeau ; I. Bourdeix | Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study. |
| 000200 (2001) |
O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. |
| 000283 (2002) |
Elena Moro [France] ; Rianne J A. Esselink ; Alim Louis Benabid ; Pierre Pollak | Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. |
| 000295 (2003) |
S. Thobois [France] ; S. Corvaisier ; P. Mertens ; C. Di Guardo ; H. Mollion ; M. Guenot ; F. Rochefort ; G. Chazot ; M. Sindou ; E. Broussolle | The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation. |
| 000318 (2003) |
A. Cormier [France] ; C. Morin ; R. Zini ; J-P Tillement ; G. Lagrue | Nicotine protects rat brain mitochondria against experimental injuries. |
| 000320 (2003) |
Marc Ziegler [France] ; Alexandre Castro-Caldas ; Susanna Del Signore ; Olivier Rascol | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study. |
| 000347 (2003) |
Olivier Rascol [France] | Monoamine oxidase inhibitors--is it time to up the TEMPO? |
| 000384 (2003) |
A. Lannuzel [France] ; P P Michel ; G U Höglinger ; P. Champy ; A. Jousset ; F. Medja ; A. Lombès ; F. Darios ; C. Gleye ; A. Laurens ; R. Hocquemiller ; E C Hirsch ; M. Ruberg | The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. |
| 000434 (2004) |
P. Pollak ; F. Tison ; O. Rascol ; A. Destee ; J. Pere ; J. Senard ; F. Durif ; I. Bourdeix | Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up |
| 000447 (2003) |
Olivier Blin [France] | The pharmacokinetics of pergolide in Parkinson's disease. |
| 000505 (2005) |
Nicolas Simon [France] ; Joëlle Micallef ; Jean-Charles Reynier ; Monique Lesourd ; Tatiana Witjas ; André Alicherif ; Jean-Philippe Azulay ; Olivier Blin | End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study. |
| 000534 (????) |
Claire Thalamas [France] ; Iris Rajman ; Jaime Kulisevsky ; Alberto Lled ; Alison E. Mackie ; Olivier Blin ; Todd A. Gillespie ; Mary Seger ; Olivier Rascol | Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease. |
| 000588 (2006) |
Stéphane Thobois [France] | Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature. |
| 000601 (1991) |
D. Milon [France] ; H. Allain ; D. Bentue-Ferrer ; J P Martinet ; M H Lemaitre ; R. Decombe | Cardiac beta-adrenoceptor sensitivity and Parkinson's disease. |
| 000620 (2006) |
Emuri Abe ; Jean-Claude Alvarez | Sensitive quantification of apomorphine in human plasma using a LC-ESI-MS-MS method. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dose-Response Relationship, Drug"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Dose-Response Relationship, Drug" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Dose-Response Relationship, Drug
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
